Flash Therapeutics
Flash Therapeutics is a new gene therapy company developing gene and cell-based therapies by leveraging its proprietary lentiviral platform.
Flash Therapeutics has raised €15M across 1 funding round from 2 investors, most recently a round in Sep 2021. Based in Toulouse, France; active in Healthtech. Data as of 28 Oct 2026.
Toulouse, Francewww.flashtherapeutics.com ↗
Total raised
€15M
€15,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2021-09
latest 2021-09
Funding by year
EUR raised per yearFlash Therapeutics — funding by year — interactive chart.
Data table
| Flash Therapeutics — funding by year | |
|---|---|
| 2021 | €15M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-09-07 | Other | €15M | Elaia Partners,TechLife Capital | View deal → |
Investors
2Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData